Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 3—March 2015

Autochthonous Dengue Fever, Tokyo, Japan, 2014

Satoshi KutsunaComments to Author , Yasuyuki Kato, Meng Ling Moi, Akira Kotaki, Masayuki Ota, Koh Shinohara, Tetsuro Kobayashi, Kei Yamamoto, Yoshihiro Fujiya, Momoko Mawatari, Tastuya Sato, Junwa Kunimatsu, Nozomi Takeshita, Kayoko Hayakawa, Shuzo Kanagawa, Tomohiko Takasaki, and Norio Ohmagari
Author affiliations: National Center for Global Health and Medicine, Tokyo, Japan (S. Kutsuna, Y. Kato, M. Ota, K. Shinohara, T. Kobayashi, K. Yamamoto, Y. Fujiya, M. Mawatari, T. Sato, J. Kunimatsu, N. Takeshita, K. Hayakawa, S. Kanagawa, N. Ohmagari); National Institute of Infectious Diseases, Tokyo (M.L. Moi, A. Kotaki, T. Takasaki)

Main Article

Table 2

Laboratory findings for 19 patients with dengue fever, Tokyo, Japan, August 26, 2014–September 22, 2014

Laboratory finding at first visit
Reference range
Patient median (interquartile range)
Leukocytes, cells /mm³ 3,500-8,500 2,600 (2,385–3,540)
Hematocrit, % M 40–50, F 35–45 41.8 (38.5–42.9)
Platelets, ×103/μL 150–350 115 (79–150)
Aspartate transaminase, IU/L 13–33 35 (22–41)
Alanine transaminase, IU/L 8–42 20 (14–26)
Lactate dehydrogenase, IU/L 119–229 227 (166–261)
C-reactive protein, mg/L 0–0.3 6.1 (2.2–16.1)

Main Article

Page created: November 02, 2017
Page updated: November 02, 2017
Page reviewed: November 02, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.